Cardiovascular late effects.
This integrative literature review focuses on (1) the spectrum of cardiovascular late effects; (2) the factors that can influence the development of cardiovascular late effects; and (3) the role of the pediatric oncology nurse in minimizing the risks of cardiovascular late effects and associated disabilities in childhood cancer survivorship. The results showed that survivors who have been treated with radiation therapy, especially when the field includes the heart or the hypothalamic-pituitary axis (HPA), and specific chemotherapies are at increased risk for developing particular cardiovascular risk factors and/or cardiovascular disease. Younger age at diagnosis, longer time since treatment, and family history of early heart disease can further heighten the risks. The role of pediatric oncology nurses in the promotion of cardiovascular health for children with cancer across the illness trajectory is discussed.
Greving
Dawn M
DM
Hematology/Oncology Division, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, USA. dawn.greving@cchmc.org
Santacroce
Sheila Judge
SJ
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000517:prevention & control; D002648:Child; D004734:Energy Metabolism; D006801:Humans; D020380:Needs Assessment; D009369:Neoplasms / Q000188:drug therapy* / Q000451:nursing; D024802:Nurse's Role; D009765:Obesity / Q000139:chemically induced / Q000378:metabolism / Q000517:prevention & control; D009859:Oncology Nursing / Q000458:organization & administration*; D010353:Patient Education as Topic; D010371:Pediatric Nursing / Q000458:organization & administration*; D011322:Primary Prevention / Q000458:organization & administration; D012307:Risk Factors; D040242:Risk Reduction Behavior; D017741:Survivors; D013997:Time Factors
D000970:Antineoplastic Agents